Bolt Biotherapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-07. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| Edgar Engleman | Director | Palo Alto, CA |
| James Healy | Director | Sunnyvale, CA |
| Ashish Khanna | Director | South San Francisco, CA |
| Kathleen LaPorte | Director | Redwood City, CA |
| Richard Miller | Director | Waxahachie, TX |
| Peter Moldt | Director | Seattle, WA |
| Randall Schatzman | Director | Seattle, WA |
| Mahendra Shah | Director | Palo Alto, CA |
| David Dornan | Executive Officer | MORRISTOWN, NJ |
| Edith Perez | Executive Officer | Redwood City, CA |
| WILLIAM QUINN | Executive Officer | Morgantown, WV |
| Randall Schatzman | Executive Officer | Seattle, WA |
| Grant Yonehiro | Executive Officer | Redwood City, CA |
| Edgar Engleman | Executive Officer | Palo Alto, CA |
| Reiner Laus | Director | San Diego, CA |
| Reiner Laus | Executive Officer | San Diego, CA |
| Chih-Ping Liu | Director | Portola Valley, CA |
| Chih-Ping Liu | Executive Officer | Portola Valley, CA |
| Chih-Ping Liu | Promoter | Portola Valley, CA |
| Ashish G Khanna | Director | Redwood City, CA |
| Grant G Yonehiro | Executive Officer | Redwood City, CA |
| Peter G Moldt | Director | Redwood City, CA |
| Ken G Harrison | Director | Redwood City, CA |
| Peter G Bisgaard | Director | Pleasanton, CA |
| Mahendra G Shah | Director | TURKU, H9 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-01-28 | D | $93.5M | $93.5M |
| 2019-07-15 | D | $40.1M | $40.1M |
| 2018-08-06 | D | $13.4M | $13.4M |
| 2018-02-20 | D | $6.0M | $6.0M |
| 2016-09-30 | D | $16.0M | $10.0M |
| 2015-05-07 | D | $800K | $600K |